Viral Vector & Plasmid DNA Manufacturing Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Viral Vector & Plasmid DNA Manufacturing Market to 2027 - Global Analysis and Forecasts By Product (Viral Vectors, Non-Viral Vectors and Plasmid DNA), Application (Cancer, Genetic Disorders, Infectious Diseases, and Other Applications) and Geography

Report Code: TIPRE00003074 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Plasmid DNA and viral vectors are the products obtained due to gene therapy. These products are used for the treatment of various diseases. Viral vectors and plasmid DNA help in the development of new vaccines, which can be used to treat various chronic diseases. With a rise in the prevalence of diseases and the need to discover better vaccines is expected fuel the demand for viral vector and plasmid DNA manufacturing market.

Technological advancements for the production of viral vectors and their increasing acceptance for vaccine production is expected to fuel the growth of the viral vector & plasmid DNA manufacturing market during the forecast period. Moreover, strategic activities such as, collaboration & partnerships in the field of cell and gene therapy is anticipated to offer significant growth opportunities in the market.
The "Global Viral Vector & Plasmid DNA Manufacturing Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application and geography. The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading viral vector & plasmid DNA manufacturing market players and offers key trends and opportunities in the market.

The global viral vector & plasmid DNA manufacturing market is segmented on the basis of product and application. Based on product, the market is categorized as, viral vectors, non-viral vectors and plasmid DNA. Similarly, on the basis of application, the market is segmented as, cancer, genetic disorders, infectious diseases, and other applications.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global viral vector & plasmid DNA manufacturing market based on product and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The viral vector & plasmid DNA manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the viral vector & plasmid DNA manufacturing market in the coming years, owing to the strong presence of biopharma companies in the region, leading to increased demand for viral vectors. Also, Asia Pacific is anticipated to witness significant growth in the market during the forecast period, rising R&D activities for development of new vaccines in countries such as China and India.

The report analyzes factors affecting viral vector & plasmid DNA manufacturing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the viral vector & plasmid DNA manufacturing market in these regions.

The report also includes the profiles of key viral vector & plasmid DNA manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the viral vector & plasmid DNA manufacturing market include, Cobra Biologics, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Genezen, Lonza, Merck KGaA, New England Biolabs, Novasep, Oxford BioMedica, Spark Therapeutics, Inc., and Waisman Biomanufacturing among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Viral Vector & Plasmid DNA Manufacturing Market- By Product
1.3.2. Viral Vector & Plasmid DNA Manufacturing Market- By Application
1.3.3. Viral Vector & Plasmid DNA Manufacturing Market- By Region
1.3.3.1. By Country

2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET- GLOBAL ANALYSIS
6.1. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET - GLOBAL MARKET OVERVIEW
6.2. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. VIRAL VECTORS MARKET
7.3.1. Overview
7.3.2. Viral Vectors Market Forecast and Analysis (US$ Mn)
7.4. NON-VIRAL VECTORS MARKET
7.4.1. Overview
7.4.2. Non-Viral Vectors Market Forecast and Analysis (US$ Mn)
7.5. PLASMID DNA MARKET
7.5.1. Overview
7.5.2. Plasmid DNA Market Forecast and Analysis (US$ Mn)

8. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER MARKET
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis (US$ Mn)
8.4. GENETIC DISORDERS MARKET
8.4.1. Overview
8.4.2. Genetic Disorders Market Forecast and Analysis (US$ Mn)
8.5. INFECTIOUS DISEASES MARKET
8.5.1. Overview
8.5.2. Infectious Diseases Market Forecast and Analysis (US$ Mn)
8.6. OTHER APPLICATIONS MARKET
8.6.1. Overview
8.6.2. Other Applications Market Forecast and Analysis (US$ Mn)

9. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET
9.1.1. North America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis (US$ Mn)
9.1.2. North America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.1.3. North America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.1.4. North America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Country
9.1.5. US Market Overview
9.1.5.1. US Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.1.5.2. US Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.1.6. Canada Market Overview
9.1.6.1. Canada Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.1.6.2. Canada Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.1.7. Mexico Market Overview
9.1.7.1. Mexico Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.1.7.2. Mexico Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)

9.2. EUROPE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET
9.2.1. Europe Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis (US$ Mn)
9.2.2. Europe Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.2.3. Europe Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.2.4. Europe Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Country
9.2.5. UK Market Overview
9.2.5.1. UK Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.2.5.2. UK Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.2.6. Germany Market Overview
9.2.6.1. Germany Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.2.6.2. Germany Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.2.7. France Market Overview
9.2.7.1. France Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.2.7.2. France Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.2.8. Spain Market Overview
9.2.8.1. Spain Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.2.8.2. Spain Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.2.9. Italy Market Overview
9.2.9.1. Italy Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.2.9.2. Italy Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.3. ASIA PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET
9.3.1. Asia Pacific Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis (US$ Mn)
9.3.2. Asia Pacific Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.3.3. Asia Pacific Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.3.4. Asia Pacific Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Country
9.3.5. Japan Market Overview
9.3.5.1. Japan Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.3.5.2. Japan Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.3.6. China Market Overview
9.3.6.1. China Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.3.6.2. China Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.3.7. India Market Overview
9.3.7.1. India Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.3.7.2. India Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.3.8. Australia Market Overview
9.3.8.1. Australia Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.3.8.2. Australia Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.3.9. South Korea Market Overview
9.3.9.1. South Korea Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.3.9.2. South Korea Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.4. MIDDLE EAST & AFRICA (MEA) VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET
9.4.1. Middle East & Africa (MEA) Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis (US$ Mn)
9.4.2. Middle East & Africa (MEA) Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.4.3. Middle East & Africa (MEA) Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.4.4. Middle East & Africa (MEA) Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Country
9.4.5. South Africa Market Overview
9.4.5.1. South Africa Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.4.5.2. South Africa Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.4.6. Saudi Arabia Market Overview
9.4.6.1. Saudi Arabia Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.4.6.2. Saudi Arabia Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.4.7. UAE Market Overview
9.4.7.1. UAE Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.4.7.2. UAE Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.5. SOUTH AND CENTRAL AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET
9.5.1. South and Central America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis (US$ Mn)
9.5.2. South and Central America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.5.3. South and Central America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.5.4. South and Central America Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Country
9.5.5. Brazil Market Overview
9.5.5.1. Brazil Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.5.5.2. Brazil Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)
9.5.6. Argentina Market Overview
9.5.6.1. Argentina Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Product (US$ Mn)
9.5.6.2. Argentina Viral Vector & Plasmid DNA Manufacturing Market Forecasts and Analysis - By Application (US$ Mn)

10. INDUSTRY LANDSCAPE
1.1. ORGANIC GROWTH STRATEGIES
1.1.1. New Product Launches
1.1.2. Marketing & Promotional Activities
1.2. INORGANIC GROWTH STRATEGIES
1.2.1. Partnerships, Collaborations, and Joint Ventures
1.2.2. Mergers & Acquisitions

11. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET, KEY COMPANY PROFILES
11.1. COBRA BIOLOGICS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GENEZEN
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. SWOT Analysis
11.3.6. Key Developments

11.4. LONZA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK KGAA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NEW ENGLAND BIOLABS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVASEP
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. OXFORD BIOMEDICA
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SPARK THERAPEUTICS, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. WAISMAN BIOMANUFACTURING
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Cobra Biologics
2. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
3. Genezen
4. Lonza
5. Merck KGaA
6. New England Biolabs
7. Novasep
8. Oxford BioMedica
9. Spark Therapeutics, Inc.
10. Waisman Biomanufacturing